Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Pifithrin

From Wikipedia, the free encyclopedia
Pifithrin-α
Names
IUPAC name
2-amino-3-[2-(4-methylphenyl)-2-oxoethyl]-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-2-ylium bromide
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
KEGG
UNII
  • InChI=1S/C16H18N2OS.BrH/c1-11-6-8-12(9-7-11)14(19)10-18-13-4-2-3-5-15(13)20-16(18)17;/h6-9,17H,2-5,10H2,1H3;1H checkY
    Key: HAGVCKULCLQGRF-UHFFFAOYSA-N checkY
  • α: InChI=1/C16H19N2OS.BrH/c1-11-6-8-12(9-7-11)14(19)10-18-13-4-2-3-5-15(13)20-16(18)17;/h6-9H,2-5,10,17H2,1H3;1H/q+1;/p-1
    Key: KXMMOFYVZLFBEG-REWHXWOFAW
  • β: InChI=1S/C16H16N2S/c1-11-6-8-12(9-7-11)13-10-18-14-4-2-3-5-15(14)19-16(18)17-13/h6-10H,2-5H2,1H3
  • α: CC1=CC=C(C=C1)C(=O)CN2C3=C(CCCC3)SC2=N
  • β: CC1=CC=C(C=C1)C2=CN3C4=C(CCCC4)SC3=N2
  • [Br-].Cc1ccc(cc1)C(=O)Cn2[c+](N)sc3CCCCc23
Properties
C16H19BrN2OS
Molar mass 367.30 g/mol
Melting point 192.1 °C (377.8 °F; 465.2 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X markN verify (what is checkYX markN ?)

Pifithrin-α (chemical name 2-(2-Imino-4,5,6,7-tetrahydrobenzothiazol-3-yl)-1-p-tolylethanone hydrobromide[1]) is a chemical compound which acts as an inhibitor of the tumour-suppressing and epileptogenic protein p53.[2][3] It has a molecular weight of 367.30 and is soluble in DMSO up to 20 mg/mL. Its melting point is 192.1-192.5 °C.

References

[edit]
  1. "sigmaaldrich.com". Merck.
  2. George, SL; Parmar, V; Lorenzi, F; Marshall, LV; Jamin, Y; Poon, E; Angelini, P; Chesler, L (May 2020). "Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma". J Exp Clin Cancer Res. 39 (1): 78. doi:10.1186/s13046-020-01582-2. PMC 7201617. PMID 32375866.
  3. Gupta, V; Singh, S; Singh, TG (Nov 2024). "Pervasive expostulation of p53 gene promoting the precipitation of neurogenic convulsions: A journey in therapeutic advancements". Eur J Pharmacol. 983 176990. doi:10.1016/j.ejphar.2024.176990. PMID 39251181.